Allergan Inc. v Sandoz Canada Inc. et al.
2018
T-2023-18
Resolved
New PM(NOC) Regulations
Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team
Carol Hitchman
Counsel
Meghan A. Dureen, Ph.D.
Counsel